Private Advisory Group LLC purchased a new stake in shares of Centene Corporation (NYSE:CNC – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 21,450 shares of the company’s stock, valued at approximately $1,332,000.
Other hedge funds and other institutional investors have also modified their holdings of the company. BlackRock Inc. acquired a new position in Centene during the 2nd quarter worth $2,660,422,000. Wellington Management Group LLP increased its stake in shares of Centene by 423.0% in the 2nd quarter. Wellington Management Group LLP now owns 13,301,215 shares of the company’s stock valued at $853,805,000 after buying an additional 10,757,914 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Centene by 12.4% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,517,580 shares of the company’s stock worth $354,173,000 after acquiring an additional 608,249 shares during the last quarter. Assenagon Asset Management S.A. raised its position in shares of Centene by 21.6% during the third quarter. Assenagon Asset Management S.A. now owns 4,518,785 shares of the company’s stock worth $302,818,000 after acquiring an additional 802,756 shares during the last quarter. Finally, Bank of America Corp DE acquired a new position in shares of Centene during the second quarter valued at $285,713,000. Institutional investors and hedge funds own 93.63% of the company’s stock.
Insider Activity at Centene
In other Centene news, General Counsel Christopher Koster sold 56,500 shares of the stock in a transaction on Wednesday, August 26th. The shares were sold at an average price of $66.90, for a total value of $3,779,850.00. Following the completion of the sale, the general counsel owned 248,854 shares in the company, valued at $16,648,332.60. This trade represents a 18.50% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 0.37% of the company’s stock.
Wall Street Analysts Forecast Growth
CNC has been the subject of several recent research reports. Argus raised Centene from a “hold” rating to a “buy” rating and set a $80.00 price objective for the company in a report on Tuesday, August 11th. Raymond James Financial set a $79.00 target price on shares of Centene in a research note on Wednesday, October 28th. Zacks Research cut shares of Centene from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 5th. Truist Financial reissued a “buy” rating and set a $82.00 price target (up from $80.00) on shares of Centene in a research note on Monday, November 2nd. Finally, Wall Street Zen lowered shares of Centene from a “strong-buy” rating to a “buy” rating in a report on Saturday, October 31st. Nine analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $73.80.
Read Our Latest Stock Analysis on Centene
Centene Stock Performance
Shares of CNC stock opened at $71.23 on Monday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.16 and a current ratio of 1.16. The company has a market capitalization of $35.27 billion, a P/E ratio of 24.40, a price-to-earnings-growth ratio of 0.42 and a beta of 1.07. The company’s 50 day moving average price is $67.07 and its two-hundred day moving average price is $56.51. Centene Corporation has a 52 week low of $31.63 and a 52 week high of $78.08.
Centene (NYSE:CNC – Get Free Report) last released its earnings results on Tuesday, October 27th. The company reported $0.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.10 by $0.48. Centene had a return on equity of 12.15% and a net margin of 0.72%. The firm had revenue of $50.65 billion during the quarter, compared to analysts’ expectations of $47.12 billion. During the same quarter in the prior year, the company earned $0.50 EPS. The company’s revenue was up 1.9% on a year-over-year basis. On average, analysts expect that Centene Corporation will post 5.27 earnings per share for the current fiscal year.
About Centene
Centene Corporation is a U.S. health care company that provides managed care and related services, primarily for people enrolled in government-sponsored health programs. Its offerings include Medicaid and Medicare plans, as well as health insurance sold through the Affordable Care Act marketplace. Centene serves members through health plans and a network of health care providers. Its businesses include Ambetter, which offers marketplace health plans, and Wellcare, which provides Medicare-related coverage.
Featured Stories
- Five stocks we like better than Centene
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
